UNeMed Corporation is a renowned technology transfer and commercialization office (TTO) that represents the University of Nebraska Medical Center (UNMC) and the University of Nebraska at Omaha (UNO). With a mission to foster innovation and advance research, UNeMed plays a vital role in bringing novel technologies to the marketplace. Since its establishment in 1991, UNeMed has built partnerships with industry leaders to drive the translation of biomedical technology from the laboratory to the real world.

Whether it's through launching startup companies, licensing agreements with multinational corporations, or securing sponsored research support, UNeMed utilizes various tools to ensure the successful commercialization of cutting-edge inventions. Their product and service offerings include Confidentiality, Intellectual Property, Inventions, Licensing Process, Material Transfer, Startup Formation, and an impressive Technology Portfolio spanning diverse fields such as Cancer, Cardiovascular, COVID-19, Drug Delivery, Infectious Diseases, Medical Devices, Metabolic, Neurologic, Open-MediciNE, Other Research Tools, and Software. By collaborating with entrepreneurs, industries, and researchers, UNeMed strives to create a happier and healthier world through innovative technology